Online Course: Exclusivities, Extensions, and Exemptions in The Pharmaceutical Industry

Seminar

Online

Preis auf Anfrage

Beschreibung

  • Kursart

    Seminar

  • Methodik

    Online

This online practical training course teaches IP professionals in the pharmaceutical industry what they need to know about regulatory affairs.

Fragen & Antworten

Ihre Frage hinzufügen

Unsere Berater und andere Nutzer werden Ihnen antworten können

Wer möchten Sie Ihre Frage beantworten?

Geben Sie Ihre Kontaktdaten ein, um eine Antwort zu erhalten

Es werden nur Ihr Name und Ihre Frage veröffentlicht.

Emagister S.L. (Verantwortlicher) verarbeitet deine Daten, um Werbeaktionen (per E-Mail und/oder Telefon) durchzuführen, Bewertungen zu veröffentlichen oder Vorfälle zu bearbeiten. In der Datenschutzrichtlinie erfährst du mehr über deine Rechte und kannst dich abmelden.

Meinungen

Erfolge dieses Bildungszentrums

2020

Sämtlich Kurse sind auf dem neuesten Stand

Die Durchschnittsbewertung liegt über 3,7

Mehr als 50 Meinungen in den letzten 12 Monaten

Dieses Bildungszentrum ist seit 17 Mitglied auf Emagister

Themen

  • Basic
  • Extension
  • Marketing

Inhalte

Detailed programme Intensive Course: Each day from 13:00-17:15 CET
Pre-Meeting on 28 June 2021 from 14:00 to 15:00 CET
Regulatory exclusivities
  • Types of procedures to obtain a marketing authorization in the European Union
  • Data and market exclusivity
  • Protection periods
  • Orphan drugs
  • Patent term extensions
  • Supplemental Protection Certificates (SPCs) in the EU
  • Patent Term Extensions (PTEs) in the US
  • Pediatric Extensions
  • Patent linkage (the US-FDA Orange Book)
  • Exemptions from IP protection
  • Research exemptions
  • Bolar exemptions
  • The SPC manufacturing waiver
  • Case study: Assembling the principal exclusivities, extensions and exemptions for a drug
  • How and where to obtain the relevant data for the EU
  • Determination of the relevant data for the US
  • Preparation of a chart/overview

  • Detailed programme Intensive Course: Each day from 13:00-17:15 CET
    Pre-Meeting on 28 June 2021 from 14:00 to 15:00 CET
    Regulatory exclusivities
  • Types of procedures to obtain a marketing authorization in the European Union
  • Data and market exclusivity
  • Protection periods
  • Orphan drugs
  • Patent term extensions
  • Supplemental Protection Certificates (SPCs) in the EU
  • Patent Term Extensions (PTEs) in the US
  • Pediatric Extensions
  • Patent linkage (the US-FDA Orange Book)
  • Exemptions from IP protection
  • Research exemptions
  • Bolar exemptions
  • The SPC manufacturing waiver
  • Case study: Assembling the principal exclusivities, extensions and exemptions for a drug
  • How and where to obtain the relevant data for the EU
  • Determination of the relevant data for the US
  • Preparation of a chart/overview

  • Detailed programme
    Detailed programme
    Intensive Course: Each day from 13:00-17:15 CET
    Pre-Meeting on 28 June 2021 from 14:00 to 15:00 CET

    Intensive Course: Each day from 13:00-17:15 CET
    Pre-Meeting on 28 June 2021 from 14:00 to 15:00 CET Regulatory exclusivities
  • Types of procedures to obtain a marketing authorization in the European Union
  • Data and market exclusivity
  • Protection periods
  • Orphan drugs
  • Patent term extensions
  • Supplemental Protection Certificates (SPCs) in the EU
  • Patent Term Extensions (PTEs) in the US
  • Pediatric Extensions
  • Patent linkage (the US-FDA Orange Book)
  • Exemptions from IP protection
  • Research exemptions
  • Bolar exemptions
  • The SPC manufacturing waiver
  • Case study: Assembling the principal exclusivities, extensions and exemptions for a drug
  • How and where to obtain the relevant data for the EU
  • Determination of the relevant data for the US
  • Preparation of a chart/overview

  • Regulatory exclusivities
  • Types of procedures to obtain a marketing authorization in the European Union
  • Data and market exclusivity
  • Protection periods
  • Orphan drugs
  • Patent term extensions
  • Supplemental Protection Certificates (SPCs) in the EU
  • Patent Term Extensions (PTEs) in the US
  • Pediatric Extensions
  • Patent linkage (the US-FDA Orange Book)
  • Exemptions from IP protection
  • Research exemptions
  • Bolar exemptions
  • The SPC manufacturing waiver
  • Case study: Assembling the principal exclusivities, extensions and exemptions for a drug
  • How and where to obtain the relevant data for the EU
  • Determination of the relevant data for the US
  • Preparation of a chart/overview

  • Regulatory exclusivities
  • Types of procedures to obtain a marketing authorization in the European Union
  • Data and market exclusivity
  • Protection periods
  • Orphan drugs

  • Online Course: Exclusivities, Extensions, and Exemptions in The Pharmaceutical Industry

    Preis auf Anfrage